This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Commissariat a L'energie Atomique Et Aux Energies Alternatives, National Institute of Health and Medical Research. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2012
Title: Michel Ronjat: Innovator in Intracellular Delivery Systems
Introduction
Michel Ronjat is a notable inventor based in Vaulnaveys le Haut, France. He has made significant contributions to the field of biochemistry, particularly in the development of peptide vectors for intracellular delivery. His innovative work has led to the filing of a patent that showcases his expertise and creativity in addressing complex scientific challenges.
Latest Patents
Michel Ronjat holds a patent titled "Peptides derived from maurocalcine used as vectors for intracellular addressing of molecules of interest." This patent describes a method for the intracellular delivery of substances, utilizing a maurocalcine-derived peptide vector. The vector is characterized by a specific sequence that facilitates the transport of substances into cells, enhancing the efficacy of drug delivery systems.
Career Highlights
Throughout his career, Michel Ronjat has worked with prestigious organizations, including the Commissariat à l'Énergie Atomique et aux Énergies Alternatives and the National Institute of Health and Medical Research. His experience in these institutions has allowed him to collaborate with leading scientists and contribute to groundbreaking research in the field of molecular biology.
Collaborations
One of his notable collaborators is Michel De Waard, with whom he has worked on various projects aimed at advancing the understanding of peptide vectors and their applications in medicine.
Conclusion
Michel Ronjat's innovative work in the field of intracellular delivery systems exemplifies the impact of scientific research on modern medicine. His contributions continue to inspire future advancements in biochemistry and drug delivery technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile